Condition

Recurrent Prostate Carcinoma

ClinicalTrials.gov condition label

Clinical trials63
Recruiting4
Common interventions25
Lead sponsors shown15

Clinical trials

60 shown
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT TrialNCT07202247 · 2025-11-05
RECRUITING
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac TrialNCT06650579 · 2025-01-31
RECRUITING
99mTc-PSMA-I&S Biodistribution in Patients With Prostate CancerNCT04857502 · 2021-04-27
RECRUITING
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerNCT01050504 · 2009-08-01
RECRUITING
Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate CancerNCT05779943 · 2023-04-27
ACTIVE_NOT_RECRUITING
SMMART Adaptive Clinical Treatment (ACT) TrialNCT05238831 · 2023-01-30
WITHDRAWN
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal CancersNCT05722288 · 2023-01-20
ACTIVE_NOT_RECRUITING
Gallium-68 PSMA-11 PET in Participants With Prostate CancerNCT05034562 · 2022-09-26
WITHDRAWN
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVNCT04514484 · 2021-11-22
ACTIVE_NOT_RECRUITING
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CANCT04519879 · 2021-05-10
SUSPENDED
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsNCT04550494 · 2021-04-26
ACTIVE_NOT_RECRUITING
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate CancerNCT03902951 · 2021-03-17
ACTIVE_NOT_RECRUITING
Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate CancerNCT03698370 · 2020-12-15
COMPLETED
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology ValidationNCT04457232 · 2020-09-09
ACTIVE_NOT_RECRUITING
A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate CancerNCT04190446 · 2020-01-06
ACTIVE_NOT_RECRUITING
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate CancerNCT03796767 · 2019-09-09
COMPLETED
Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After SurgeryNCT03515577 · 2019-04-12
COMPLETED
Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical ProstatectomyNCT03582774 · 2018-07-12
ACTIVE_NOT_RECRUITING
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE TrialNCT03371719 · 2018-06-20
ACTIVE_NOT_RECRUITING
Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate CancerNCT02881242 · 2018-01-30
ACTIVE_NOT_RECRUITING
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial TreatmentNCT02673151 · 2017-05-20
COMPLETED
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate CancerNCT03016741 · 2017-03-31
ACTIVE_NOT_RECRUITING
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After RadiationNCT02899221 · 2017-03-21
COMPLETED
Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate CancerNCT03122743 · 2017-02-22
COMPLETED
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate CancerNCT02935205 · 2017-01-17
UNKNOWN
Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate CancerNCT03123978 · 2017-01-09
COMPLETED
Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair DeficienciesNCT02985021 · 2016-11-01
TERMINATED
Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate CancerNCT02807805 · 2016-10-01
ACTIVE_NOT_RECRUITING
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial TherapyNCT02940262 · 2016-09-15
COMPLETED
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7NCT02601014 · 2016-03-15
COMPLETED
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsNCT02646319 · 2016-01-01
COMPLETED
Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate CancerNCT02532114 · 2015-12-31
COMPLETED
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17
ACTIVE_NOT_RECRUITING
Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate CancerNCT02522715 · 2015-08-13
ACTIVE_NOT_RECRUITING
Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate CancerNCT02499835 · 2015-07-01
COMPLETED
Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation TherapyNCT02420652 · 2015-06-23
TERMINATED
68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate CancerNCT02488070 · 2015-06-01
COMPLETED
Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate CancerNCT02159950 · 2015-01-01
COMPLETED
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With EnzalutamideNCT02312557 · 2014-11-18
ACTIVE_NOT_RECRUITING
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerNCT02206334 · 2014-08-01
COMPLETED
Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide TherapyNCT02099864 · 2014-02-05
COMPLETED
Itraconazole in Treating Patients With Biochemically Relapsed Prostate CancerNCT01787331 · 2013-10-29
COMPLETED
Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-TNCT01833208 · 2013-07-03
COMPLETED
Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition TherapyNCT01953640 · 2013-05-30
COMPLETED
Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving EnzalutamideNCT02228265 · 2013-03-12
COMPLETED
Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate CancerNCT01786265 · 2013-02-05
ACTIVE_NOT_RECRUITING
Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate CancerNCT01503229 · 2012-12-01
COMPLETED
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionNCT01638533 · 2012-08-03
COMPLETED
Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate CancerNCT01576172 · 2012-03-30
COMPLETED
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsNCT01522820 · 2012-03-01
COMPLETED
Tivantinib in Treating Patients With Metastatic Prostate CancerNCT01519414 · 2012-01-11
COMPLETED
Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerNCT01251861 · 2011-03-17
COMPLETED
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerNCT01120236 · 2010-12-01
COMPLETED
Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate CancerNCT01145508 · 2010-08-01
TERMINATED
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With DocetaxelNCT01253642 · 2010-07-12
TERMINATED
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate CancerNCT01026623 · 2009-10-01
COMPLETED
Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone MetastasesNCT00936975 · 2009-09-01
COMPLETED
Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyNCT00486642 · 2007-09-01
COMPLETED
Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate CancerNCT00536991 · 2006-10-01
TERMINATED
A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate CancerNCT00108732 · 2006-02-01
COMPLETED

Common interventions

Laboratory Biomarker AnalysisOTHER29Computed TomographyPROCEDURE13Pharmacological StudyOTHER11Biospecimen CollectionPROCEDURE9EnzalutamideDRUG9Positron Emission TomographyPROCEDURE8PrednisoneDRUG8Quality-of-Life AssessmentOTHER8Abiraterone AcetateDRUG7BicalutamideDRUG7Questionnaire AdministrationOTHER7Magnetic Resonance ImagingPROCEDURE6Goserelin AcetateDRUG4Leuprolide AcetateDRUG4Cytology Specimen Collection ProcedureOTHER3DocetaxelDRUG3NiclosamideDRUG3NivolumabBIOLOGICAL3Radiation TherapyRADIATION3ApalutamideDRUG2Biopsy ProcedurePROCEDURE2CarboplatinDRUG2CixutumumabBIOLOGICAL2Clinical ObservationOTHER2FlutamideDRUG2

Trial status mix

COMPLETED33
ACTIVE_NOT_RECRUITING16
TERMINATED5
RECRUITING4
WITHDRAWN2
NO_LONGER_AVAILABLE1
SUSPENDED1
UNKNOWN1

Phase mix

PHASE241
PHASE114
PHASE34
EARLY_PHASE13
NA2
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.